Subsidizing the Distribution Channel : Donor Funding to Improve the Availability of Products with Positive Externalities

January 2011 Abstract Large populations in the developing world lack adequate access to products, such as essential medicines, whose use confers positive externalities. Because of the critical role played by the privatesector distribution channel, donors (e.g., the Global Fund) are beginning to devote substantial resources to fund subsidies that encourage the channel to improve the availability of these products. A key question for a donor is whether it should subsidize the purchases or sales of the private channel. We find the answer depends crucially on whether consumers are homogeneous or heterogeneous in their valuation of the product. For the case of heterogeneous consumers’ valuations, we provide evidence that subsidizing sales leads to greater expected donor utility, consumption, and social welfare. When consumers’ valuations are homogeneous, we establish the opposite conclusion: subsidizing purchases leads to greater expected donor utility, consumption, and social welfare.

[1]  A. Moeller,et al.  Economics of Philanthropy , 1898, The Hospital.

[2]  A. C. Pigou Economics of welfare , 1920 .

[3]  J. Giertz,et al.  Welfare Economics and Welfare Reform , 1972 .

[4]  G. Becker A Theory of Social Interactions , 1974 .

[5]  R. Perrin,et al.  Market Intervention Policies for Increasing the Consumption of Nutrients by Low Income Households , 1981 .

[6]  K. Arrow Gifts and Exchanges , 1982 .

[7]  Gary L. Lilien,et al.  Optimal Price Subsidy Policy for Accelerating the Diffusion Of Innovation , 1983 .

[8]  U. Spiegel,et al.  Philanthropic motives and contribution policy , 1983 .

[9]  D. Kahneman,et al.  CHAPTER EIGHT. Fairness as a Constraint on Profit Seeking: Entitlements in the Market , 2004 .

[10]  George L. Nemhauser,et al.  Handbooks in operations research and management science , 1989 .

[11]  Maqbool Dada,et al.  Pricing and the Newsvendor Problem: A Review with Extensions , 1999, Oper. Res..

[12]  Evan L. Porteus,et al.  Selling to the Newsvendor: An Analysis of Price-Only Contracts , 2001, Manuf. Serv. Oper. Manag..

[13]  Terry A. Taylor,et al.  Supply Chain Coordination Under Channel Rebates with Sales Effort Effects , 2002, Manag. Sci..

[14]  F. Bustreo,et al.  Can developing countries achieve adequate improvements in child health outcomes without engaging the private sector? , 2003, Bulletin of the World Health Organization.

[15]  C. Lengeler,et al.  Targeted subsidy for malaria control with treated nets using a discount voucher system in Tanzania. , 2003, Health policy and planning.

[16]  D. Bell,et al.  Creating Win-Win Trade Promotions: Theory and Empirical Analysis of Scan-Back Trade Deals , 2003 .

[17]  Gérard P. Cachon Supply Chain Coordination with Contracts , 2003, Supply Chain Management.

[18]  Anne Mills,et al.  The economic impact of malaria in Africa: a critical review of the evidence. , 2003, Health policy.

[19]  Kenneth J. Arrow,et al.  Saving lives, buying time : economics of malaria drugs in an age of resistance , 2004 .

[20]  Roman Kapuscinski,et al.  Coordinating Contracts for Decentralized Supply Chains with Retailer Promotional Effort , 2004, Manag. Sci..

[21]  David L. Smith,et al.  Will a global subsidy of new antimalarials delay the emergence of resistance and save lives? , 2006, Health affairs.

[22]  K. Hanson,et al.  Costs and effects of the Tanzanian national voucher scheme for insecticide-treated nets , 2008, Malaria Journal.

[23]  Eugene D. Jaffe,et al.  What are the drivers of channel length? Distribution reform in The People's Republic of China , 2007 .

[24]  P. Olliaro,et al.  Ensuring sustained ACT production and reliable artemisinin supply , 2007, Malaria Journal.

[25]  Z. Premji,et al.  Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania , 2008, Malaria Journal.

[26]  Evan L. Porteus,et al.  Manufacturer-to-Retailer Versus Manufacturer-to-Consumer Rebates in a Supply Chain , 2008 .

[27]  D Ross-Degnan,et al.  Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis , 2009, The Lancet.

[28]  C. Goodman,et al.  Retail sector distribution chains for malaria treatment in the developing world: a review of the literature , 2010, Malaria Journal.

[29]  S. P. Kachur,et al.  Concentration and drug prices in the retail market for malaria treatment in rural Tanzania. , 2009, Health economics.

[30]  A. Talisuna,et al.  Distribution of artemisinin-based combination therapies through private-sector channels. , 2009 .

[31]  David L. Smith,et al.  Should New Antimalarial Drugs Be Subsidized? R a M a N a N L a X M I N a R a Y a N , I a N Should New Antimalarial Drugs Be Subsidized? , 2006 .

[32]  R. Atun,et al.  Universal access to malaria medicines: innovation in financing and delivery , 2010, The Lancet.

[33]  L. Conteh,et al.  Cost Implications of Improving Malaria Diagnosis: Findings from North-Eastern Tanzania , 2010, PloS one.

[34]  Justin M. Cohen,et al.  Prices, Diagnostic Tests and the Demand for Malaria Treatment: , 2010 .

[35]  L. V. Wassenhove,et al.  If Access is the Symptom, What is the Cause? Comparing Medicine and Consumer Product Supply Chains in the Developing World , 2010 .